Annual Long Term Debt
$3.58 M
+$3.58 M+100.00%
31 December 2023
Summary:
Cidara Therapeutics annual long term debt is currently $3.58 million, with the most recent change of +$3.58 million (+100.00%) on 31 December 2023. During the last 3 years, it has risen by +$3.58 million (+100.00%). CDTX annual long term debt is now -63.48% below its all-time high of $9.79 million, reached on 31 December 2016.CDTX Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$2.36 M
-$416.00 K-14.97%
30 September 2024
Summary:
Cidara Therapeutics quarterly long term debt is currently $2.36 million, with the most recent change of -$416.00 thousand (-14.97%) on 30 September 2024. Over the past year, it has dropped by -$944.00 thousand (-28.55%). CDTX quarterly long term debt is now -76.17% below its all-time high of $9.91 million, reached on 30 June 2018.CDTX Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CDTX Long Term Debt Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +100.0% | -28.6% |
3 y3 years | +100.0% | +45.8% |
5 y5 years | +100.0% | +104.5% |
CDTX Long Term Debt High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | at high | -34.4% | ||
5 y | 5 years | at high | -34.4% | ||
alltime | all time | -63.5% | -76.2% |
Cidara Therapeutics Long Term Debt History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $2.36 M(-15.0%) |
June 2024 | - | $2.78 M(-12.7%) |
Mar 2024 | - | $3.18 M(-11.0%) |
Dec 2023 | $3.58 M(>+9900.0%) | $3.58 M(+8.2%) |
Sept 2023 | - | $3.31 M(-8.2%) |
June 2023 | - | $3.60 M(>+9900.0%) |
Dec 2022 | $0.00(-100.0%) | $0.00(-100.0%) |
Sept 2022 | - | $344.00 K(-49.3%) |
June 2022 | - | $679.00 K(-32.4%) |
Mar 2022 | - | $1.00 M(-24.1%) |
Dec 2021 | $1.32 M(>+9900.0%) | $1.32 M(-18.4%) |
Sept 2021 | - | $1.62 M(>+9900.0%) |
Dec 2020 | $0.00 | $0.00(-100.0%) |
Sept 2020 | - | $245.00 K(-49.4%) |
June 2020 | - | $484.00 K(-32.4%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2020 | - | $716.00 K(-24.0%) |
Dec 2019 | $942.00 K(>+9900.0%) | $942.00 K(-18.4%) |
Sept 2019 | - | $1.16 M(-15.2%) |
June 2019 | - | $1.36 M(-12.4%) |
Mar 2019 | - | $1.55 M(>+9900.0%) |
Dec 2018 | $0.00(-100.0%) | $0.00(-100.0%) |
Sept 2018 | - | $9.25 M(-6.6%) |
June 2018 | - | $9.91 M(+26.9%) |
Mar 2018 | - | $7.81 M(+8.4%) |
Dec 2017 | $7.21 M(-26.4%) | $7.21 M(-12.0%) |
Sept 2017 | - | $8.19 M(-10.7%) |
June 2017 | - | $9.16 M(-6.6%) |
Mar 2017 | - | $9.81 M(+0.2%) |
Dec 2016 | $9.79 M(+560.4%) | $9.79 M |
Dec 2013 | $1.48 M | - |
FAQ
- What is Cidara Therapeutics annual long term debt?
- What is the all time high annual long term debt for Cidara Therapeutics?
- What is Cidara Therapeutics annual long term debt year-on-year change?
- What is Cidara Therapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for Cidara Therapeutics?
- What is Cidara Therapeutics quarterly long term debt year-on-year change?
What is Cidara Therapeutics annual long term debt?
The current annual long term debt of CDTX is $3.58 M
What is the all time high annual long term debt for Cidara Therapeutics?
Cidara Therapeutics all-time high annual long term debt is $9.79 M
What is Cidara Therapeutics annual long term debt year-on-year change?
Over the past year, CDTX annual long term debt has changed by +$3.58 M (+100.00%)
What is Cidara Therapeutics quarterly long term debt?
The current quarterly long term debt of CDTX is $2.36 M
What is the all time high quarterly long term debt for Cidara Therapeutics?
Cidara Therapeutics all-time high quarterly long term debt is $9.91 M
What is Cidara Therapeutics quarterly long term debt year-on-year change?
Over the past year, CDTX quarterly long term debt has changed by -$944.00 K (-28.55%)